Peptide Protocols

GHK-Cu Protocol: How to Cycle It, Timing & What to Expect

A GHK-Cu protocol typically runs in cycles of four to eight weeks on, followed by a two to four week break, dosed two to five times per week for injectable use depending on the goal, with the on-period following a gradual titration from a conservative start up to the effective working level. Topical use can be maintained more continuously with monitoring, while injectable cycling is essential to manage copper load. The exact dose depends on your goal, your delivery route, and your individual response, and is built for you in the MyPeptidePal Protocol Creator.

Protocols By Compound 11 min read

Epithalon Protocol: How to Cycle It, Timing & What to Expect

An Epithalon protocol runs as a short, concentrated active cycle of 10 to 20 consecutive days, dosed once daily in the evening, followed by a long off-cycle break of four to six months before the next cycle begins. Most people run two to three cycles per year, and the protocol follows a simple on/off pattern rather than a continuous-use schedule. This guide explains how the cycle is structured, what timing and frequency principles matter, what to expect week by week, and where protocols most commonly go wrong. The personalized dose is built in the MyPeptidePal Protocol Creator.

Protocols By Compound 10 min read

DSIP Protocol: How to Cycle It, Timing & What to Expect

A DSIP protocol typically runs four to eight weeks at a frequency of three to five times per week, timed one to three hours before sleep. The cycle follows a gradual titration shape rather than a hard loading phase, starting conservatively in the first week or two and stepping up based on individual response, then settling into a steady nightly rhythm through the maintenance window. After the active cycle, a two to four week break is standard before restarting. The exact dose depends on your sleep goal, your preferred delivery route, and how you respond individually, and is built in the MyPeptidePal Protocol Creator rather than fixed here.

Protocols By Compound 11 min read

CJC-1295 NO DAC Protocol: How to Cycle It, Timing & What to Expect

A CJC-1295 NO DAC protocol typically runs eight to twelve weeks at a once-daily frequency, dosed in a fasted state before bed to amplify the body's largest natural overnight growth hormone pulse. The cycle follows a gradual titration shape: the dose builds conservatively over the first few weeks, then holds steady through the rest of the cycle, followed by a four-week off period to allow the pituitary's GHRH (growth hormone releasing hormone) receptors to reset. The exact dose depends on your goal, your experience level, and whether you run it solo or stacked with Ipamorelin, and that number is built for you in the MyPeptidePal Protocol Creator.

Protocols By Compound 10 min read

CJC-1295 DAC Protocol: How to Cycle It, Timing & What to Expect

A CJC-1295 DAC protocol typically runs 8 to 12 weeks, dosed twice weekly, with the compound's half-life of roughly 6 to 8 days meaning each injection stays active in the body for well over a week. Most protocols follow a gradual titration shape rather than a sharp loading phase, starting at a lower per-injection amount in the first two weeks and stepping up every two weeks until reaching a steady maintenance level by around week seven. After the active cycle, a 4 to 6 week off-cycle break is standard, allowing GH receptors to reset and hormone levels to normalize before the next run. The personalized dose for your goals and starting point is built in the MyPeptidePal Protocol Creator, not set here.

Protocols By Compound 11 min read

CJC-1295 (NO DAC) + Ipamorelin Protocol: How to Cycle It, Timing & What to Expect

A CJC-1295 (No DAC) + Ipamorelin protocol typically runs 8 to 12 weeks on, followed by a minimum 4 week break, with the before-bed injection serving as the anchor across all frequency levels. The two peptides work through complementary receptor pathways to produce a synergistic GH pulse (a short burst of growth hormone released by the pituitary gland), and both are injected subcutaneously in a fasted state. Frequency ranges from once daily for sleep and recovery goals to three times daily for fat loss and performance, with the exact dose determined by your goal, experience level, and injection frequency, built for you in the MyPeptidePal Protocol Creator.

Protocols By Compound 10 min read

Chonluten Protocol: How to Cycle It, Timing & What to Expect

A Chonluten protocol is built around short, intensive cycles rather than the long continuous runs common with other peptides. The traditional approach runs ten to twenty days at once-daily dosing, followed by a break of several months before the next cycle, with two to three courses per year being the standard rhythm. A second format using synthetic peptide vials runs eight to sixteen weeks with gradual dose increases across the cycle. In either case, the dose is shaped by the delivery route, the specific respiratory goal, and the product format being used. The personalized number is built in the MyPeptidePal app rather than fixed universally.

Protocols By Compound 10 min read

Cerebrolysin Protocol: How to Cycle It, Timing & What to Expect

A Cerebrolysin protocol is typically structured as a four-week cycle, dosed five days on and two days off each week, followed by an off-cycle break before repeating. The cycle runs at one consistent pattern from the first session to the last, with no formal loading phase, and the dose is shaped by your goal and delivery route rather than fixed at a single number for everyone. This guide covers how the cycle is structured, what determines the dose, what to expect week by week, and the mistakes that derail most first runs, while leaving the personalized dose and schedule to the MyPeptidePal Protocol Creator.

Protocols By Compound 10 min read

Crystagen Protocol: How to Cycle It, Timing & What to Expect

A Crystagen protocol typically runs as a 12-week cycle dosed once daily, seven days a week, with no days skipped during the active period. The cycle opens with a two-week step-up titration before settling into a steady maintenance phase through week 12, followed by a four to eight week off-cycle break. Most people run one to two cycles per year. The exact dose depends on your goal, your delivery route, and where you are in the cycle, and is built for you inside the MyPeptidePal Protocol Creator.

Protocols By Compound 10 min read

Cardiogen Protocol: How to Cycle It, Timing & What to Expect

A Cardiogen protocol runs in short, defined cycles with a deliberate off-period built in from the start. The oral and sublingual route uses a 10 to 20 day cycle followed by a 3 to 6 month break, while the injectable route runs 8 to 12 weeks with a gradual titration approach and the same extended off-period. Both routes are dosed once daily, and most people using it preventively run one or two cycles per year. The personalized dose depends on the user's goal and delivery route and is built in the MyPeptidePal Protocol Creator rather than fixed for everyone.

Protocols By Compound 9 min read

Cagrilintide Protocol: How to Cycle It, Timing & What to Expect

A cagrilintide protocol is built around once-weekly subcutaneous injections, run in a slow, deliberate titration that spans roughly 12 to 16 weeks before reaching a stable maintenance dose. The cycle starts low and steps up gradually every four weeks, giving the body time to adapt before progressing. Most research protocols follow the titration with a continued maintenance phase and then a planned off-cycle break of two to four weeks, though some approaches extend maintenance longer without a formal pause. This guide covers how a cagrilintide cycle is structured, what the titration and maintenance phases look like, the principles behind once-weekly timing, what to expect week by week, and the mistakes that derail most protocols, while leaving your specific dose, cycle length, and schedule to the MyPeptidePal Protocol Creator.

Protocols By Compound 11 min read

BPC-157 + TB-500 Protocol: How to Cycle It, Timing & What to Expect

A BPC-157 + TB-500 protocol typically runs four to eight weeks, with BPC-157 dosed daily and TB-500 dosed two to three times per week on non-consecutive days, both delivered subcutaneously. The cycle follows a loading-then-maintenance shape where consistent early exposure primes the repair environment before settling into a steady rhythm, followed by a two to four week off-cycle break before any repeat round. This guide covers how the combined cycle is structured, what determines the dose for each peptide, what to expect week by week, and the mistakes that derail results, while the personalized dose, injection schedule, and exact cycle length are built in the MyPeptidePal Protocol Creator.

Protocols By Compound 10 min read

ARA-290 Protocol: How to Cycle It, Timing & What to Expect

ARA-290 protocols are typically structured as defined cycles of four to eight weeks, dosed by subcutaneous injection once daily, with a one-week titration period at the start before stepping up to the target therapeutic range. While once-daily is the standard frequency used in Phase II clinical trials, some protocols use every-other-day or twice-weekly spacing depending on the goal and cycle length. Unlike many peptides that use a distinct loading-then-maintenance shape with different dose levels, ARA-290 holds to a consistent daily dose across the cycle once titration is complete, and clinical evidence shows meaningful benefits can persist for up to four weeks after the last injection. This guide covers the full cycle structure, frequency and timing principles, what to expect week by week, and the common mistakes that derail results, while leaving the personalized dose, exact schedule, and cycle length to the MyPeptidePal Protocol Creator.

Protocols By Compound 11 min read

AOD-9604 Protocol: How to Cycle It, Timing & What to Expect

An AOD-9604 protocol typically runs 8 to 12 weeks of once-daily subcutaneous injections administered in the morning on an empty stomach, structured as a conservative titration phase in the first several weeks followed by a steady maintenance phase for the remainder. Some practitioners recommend a four-week break after a 12-week cycle, while clinical trials have run continuous daily use for up to 24 weeks without finding a need for breaks. Because the effective dose depends on your fat-loss goal, your preferred delivery route, and your individual response rather than a fixed number that fits everyone, the personalized dose is built in the MyPeptidePal Protocol Creator rather than stated here.

Protocols By Compound 10 min read

AICAR Protocol: How to Cycle It, Timing & What to Expect

An AICAR protocol typically runs eight weeks, dosed once daily via subcutaneous injection, following a gradual titration shape that starts low and steps up every two weeks until the target range is reached. After the cycle, a four-week minimum off-cycle break is standard before beginning again, with most researchers limiting themselves to two or three cycles per year. The dose for any individual is shaped by their goal, their experience with the compound, and how their body responds, and those variables are what the MyPeptidePal Protocol Creator uses to build a personalized protocol rather than a one-size number.

Protocols By Compound 10 min read